Astrana Health (ASTH) Earnings Analysis

Astrana Health (ASTH) next reports earnings on 2026-08-06, consensus EPS 0.33 USD. Last quarter (2026-05-07) it beat with EPS 0.3 USD vs 0.29 USD est (+3.4%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E 67.91.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ASTH next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.33 USD
Revenue estimate0.99B

ASTH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.3 USD0.29 USD+3.4%Beat
2026-03-020.54 USD0.15 USD+260%Beat
2025-11-060.01 USD0.47 USD-97.9%Miss
2025-08-070.19 USD0.36 USD-47.2%Miss
2025-05-080.14 USD0.23 USD-39.1%Miss
2025-02-27-0.15 USD0.22 USD-168.2%Miss

Beat rate: 2/6 (33%) over reported quarters with consensus data.

ASTH valuation and analyst view

Trailing P/E67.91
Trailing EPS0.61881 USD
Price / book2.56
Dividend yield0.00%
Market cap2.15B
Analyst consensusBuy (10 buy / 0 hold / 0 sell)
Avg price target47.5 USD

Related research pages

Frequently asked questions

When is Astrana Health (ASTH)'s next earnings date?

Astrana Health is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.33 USD and revenue estimate of 0.99B.

Did ASTH beat earnings last quarter?

In its 2026-05-07 report, ASTH posted EPS of 0.3 USD versus a 0.29 USD estimate — a beat of 3.4%.

What is ASTH's earnings track record?

Over the last 6 reported quarters with consensus data, ASTH beat estimates 2 times (33%).

What is ASTH's current P/E ratio and EPS?

ASTH trades at a trailing P/E of 67.91 on trailing EPS of 0.6188070425321918 USD.

What do analysts rate ASTH?

Analyst consensus is "Buy" across 10 ratings (0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 47.5 USD.